Jul 31, 2025 · Pegcetacoplan (brand name Empaveli) is a twice-weekly, injectable medicine that is used to treat adults with paroxysmal nocturnal hemoglobinuria (PNH) or to reduce …

By binding to and inhibiting C3, pegcetacoplan helps regulate complement activation, thereby reducing red blood cell destruction, anemia, blood clot formation, and improving bone marrow …

Sep 1, 2025 · Pegcetacoplan injection is used to treat a type of blood disease called paroxysmal nocturnal hemoglobinuria (PNH). This medicine helps reduce red blood cell destruction or …

Pegcetacoplan is in a class of medications called monoclonal antibodies. It works by blocking the activity of the part of the immune system that may damage blood cells.

EMPAVELI is a medicine that affects your immune system and may lower the ability of your immune system to fight infections. EMPAVELI increases your chance of getting serious …

Jul 30, 2025 · EMPAVELI contains pegcetacoplan, a complement inhibitor. Pegcetacoplan is a symmetrical molecule comprised of two identical pentadecapeptides covalently bound to the …

Aug 13, 2025 · What Is Pegcetacoplan and How Does It Work? Pegcetacoplan is a prescription medicine used for the treatment of paroxysmal nocturnal hemoglobinuria. Pegcetacoplan is …

Medscape - PNH dosing for Empaveli (pegcetacoplan), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost …

View pegcetacoplan information, including dose, uses, side-effects, pregnancy, breast feeding, contra-indications, monitoring requirements and directions for administration.

May 17, 2021 · Pegcetacoplan is a complement inhibitor indicated in the treatment of adults with paroxysmal nocturnal hemoglobinuria.